The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic factors and validation of prognostic nomograms in patients (pts) treated with three targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC): Results from an Italian survey.
Roberto Iacovelli
No relevant relationships to disclose
Michele Milella
No relevant relationships to disclose
Matteo Santoni
No relevant relationships to disclose
Giuseppe Di Lorenzo
No relevant relationships to disclose
Cinzia Ortega
No relevant relationships to disclose
Roberto Sabbatini
No relevant relationships to disclose
Riccardo Ricotta
No relevant relationships to disclose
Vito Lorusso
No relevant relationships to disclose
Caterina Messina
No relevant relationships to disclose
Francesco Atzori
No relevant relationships to disclose
Paolo A. Zucali
No relevant relationships to disclose
Saverio Cinieri
No relevant relationships to disclose
Alessandra Mosca
No relevant relationships to disclose
Elena Verzoni
No relevant relationships to disclose
Francesca Primi
No relevant relationships to disclose
Chiara Baratelli
No relevant relationships to disclose
Enrico Cortesi
No relevant relationships to disclose
Giacomo Carteni
No relevant relationships to disclose
Cora N. Sternberg
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose